Omada Health, Inc.

OMDA Nasdaq SEC CIK 1611115
Follow Omada Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $91.3M +34.2% vs same quarter last year
Net income $6.6M +306.1% vs same quarter last year
EPS, diluted $0.10 +266.7% vs same quarter last year
Operating cash flow $15.1M +49.4% vs same quarter last year
Revenue by quarter
$48M
$55M
$61.4M
$68M
$75.8M
$78M
$87.8M
$91.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−$100M$0$100M$200M$300MFY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$260.2M−$12.8M
FY24$169.8M−$47.1M
FY23$122.8M−$67.5M
FY22--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2565.7%−4.6%−4.9%
FY2460.6%−25.7%−27.8%
FY2357%−53.8%−55%
FY22---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0$20MFY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$16.9M
FY24−$34.8M
FY23−$50.2M
FY22-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Omada Health
  • Healthcare median
−100%−75%−50%−25%0%FY22FY23FY24FY25
Show the numbers
YearOmada HealthHealthcare median
FY25−4.9%−30.6%
FY24−27.8%−47%
FY23−55%−58%
FY22-−80.4%